Lexicon Pharmaceuticals (LXRX) Receivables - Net (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) recorded Receivables - Net of $1.64 million in Q2 2026, down 24.7% from $2.18 million a year earlier and down 86.1% from the prior quarter.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Lexicon Pharmaceuticals reported Receivables - Net of $2.38 million, down 31.4% from FY2024.
- Annual Receivables - Net has a five-year compound annual growth rate of 43.3% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $3.47 million in FY2024 (+243.9%), $1.01 million in FY2023, $28,000 in FY2022 (+100.0%) and $14,000 in FY2021 (-96.5%).
- The Q2 2026 figure is the lowest quarterly Receivables - Net since Q1 2024.
- On a year-over-year basis, Receivables - Net has declined for five consecutive quarters, with growth averaging 126.7% over the last seven quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 810.4% in Q3 2024, against a decline of 98.3% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.78 million (Q1 2026), $2.38 million (Q4 2025) and $2.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Lexicon Pharmaceuticals | 860.99 Mn | 220.29 Mn | 11.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.78 Mn |
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 11.78 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Mar 31, 2025 | 47.45 Mn |
| Dec 31, 2024 | 3.47 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.62 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 318,000.00 |
| Jun 30, 2023 | 685,000.00 |
| Mar 31, 2023 | 261,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 34,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Dec 31, 2021 | 14,000.00 |
API Access
Lexicon Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=LXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "LXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=LXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();